{"prompt": "['In the rare event when Internet connectivity is disrupted, a 24-hour notification must be', 'made to the NRG Operations Center by phone, 215-574-3191. An electronic report must', 'be submitted immediately upon re-establishment of the Internet connection.', '7.3.1', 'Expedited Reporting Methods', 'Per CTEP NCI Guidelines for Adverse Events Reporting Requirements, a CTEP-', 'AERS 24-hour notification must be submitted with 24 hours of learning of the', 'adverse event.', 'Supporting source documentation is requested by NRG as needed to complete', 'adverse event review. When submitting supporting source documentation, include the', 'protocol number, patient ID number, and CTEP-AERS ticket number on each page,', 'and contact the NRG Operations Center (215-574-3191) for source document', 'submission information.', 'A serious adverse event that meets expedited reporting criteria outlined in the AE Reporting', 'Tables but is assessed by the CTEP-AERS as \"an action not recommended\" must still be', 'reported to fulfill NRG safety reporting obligations. Sites must bypass the \"NOT recommended\"', 'assessment; the CTEP-AERS allows submission of all reports regardless of the results of the', 'assessment.', '7.3.2 Expedited Reporting Requirements for Adverse Events', 'For Arm 1: Any Phase Study Utilizing Standard of Care Radiation Therapy1', 'FDA REPORTING REQUIREMENTS FOR SERIOUS ADVERSE EVENTS (21 CFR Part 312)', 'NOTE: Investigators MUST immediately report to the sponsor ANY Serious Adverse Events, whether or', 'not they are considered related to the investigational gent(s)/intervention (21 CFR 312.64)', 'An adverse event is considered serious if it results in ANY of the following outcomes:', '1) Death', '2) A life-threatening adverse event', '3)', 'An adverse event that results in inpatient hospitalization or prolongation of existing hospitalization', 'for > 24 hours', '4) A persistent or significant incapacity or substantial disruption of the ability to conduct normal life', 'functions', '5) A congenital anomaly/birth defect.', '6) Important Medical Events (IME) that may not result in death, be life threatening, or require', 'hospitalization may be considered serious when, based upon medical judgment, they may jeopardize', 'the patient or subject and may require medical or surgical intervention to prevent one of the', 'outcomes listed in this definition. (FDA, 21 CFR 312.32; ICH E2A and ICH E6).', 'ALL SERIOUS adverse events that meet the above criteria MUST be immediately reported to the', 'NCI via CTEP-AERS within the timeframes detailed in the table below.', 'Grade 4', 'Grade 5', 'Attribution', 'Unexpected', 'Expected', 'Unexpected', 'Expected', 'NRG-GU003', '29', 'Version Date: April 26, 2019']['Unrelated', '10 day', '10 day', 'Unlikely', 'Possible', 'Probable', '24-h/5 day', '10 day', '24-h/5 day', '24-h/5 day', 'Definite', 'Expedited AE reporting timelines are defined as:', '\"24-Hour; 5 Calendar Days\" - The AE must initially be reported via CTEP-AERS within 24', 'hours of learning of the AE, followed by a complete expedited report within 5 calendar', 'days of the initial 24-hour report.', '\"10 Calendar Days\" - A complete expedited report on the AE must be submitted within 10', 'calendar days of learning of the AE.', '1Serious adverse events that occur more than 30 days after the last administration of investigational', 'agent/intervention and have an attribution of possible, probable, or definite require reporting as follows:', 'Expedited 24-hour notification followed by complete report within 5 calendar days for:', 'Unexpected Grade 4 and all Grade 5 AEs', 'For Arm 2: Phase III Study Utilizing Radiation Therapy (including chemoRT studies\u00b9', 'FDA REPORTING REQUIREMENTS FOR SERIOUS ADVERSE EVENTS (21 CFR Part 312)', 'NOTE: Investigators MUST immediately report to the sponsor ANY Serious Adverse Events, whether or not they are considered', 'related to the investigational agent(s)/intervention (21 CFR 312.64)', 'An adverse event is considered serious if it results in ANY of the following outcomes:', '1) Death', '2)', 'A life-threatening adverse event', '3)', 'An adverse event that results in inpatient hospitalization or prolongation of existing hospitalization for 24 hours', '4)', 'A persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions', '5)', 'A congenital anomaly/birth defect.', '6)', 'Important Medical Events (IME) that may not result in death, be life threatening, or require hospitalization may be', 'considered serious when, based upon medical judgment, they may jeopardize the patient or subject and may require medical', 'or surgical intervention to prevent one of the outcomes listed in this definition. (FDA, 21 CFR 312.32; ICH E2A and ICH', 'E6).', 'ALL SERIOUS adverse events that meet the above criteria MUST be immediately reported to the NCI via CTEP-AERS', 'within the timeframes detailed in the table below.', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4 & 5', 'Hospitalization', 'Timeframes', 'Timeframes', 'Timeframes', 'Timeframes', 'Resulting in', 'Hospitalization', 'Not required', '10 Calendar Days', '> 24 hrs', '24-Hour 5 Calendar Days', 'Not resulting in', 'Hospitalization', 'Not required', '10 Calendar Days', '24 hrs', 'NRG-GU003', '30', 'Version Date: April 26, 2019']\n\n###\n\n", "completion": "END"}